FI763473A - - Google Patents

Info

Publication number
FI763473A
FI763473A FI763473A FI763473A FI763473A FI 763473 A FI763473 A FI 763473A FI 763473 A FI763473 A FI 763473A FI 763473 A FI763473 A FI 763473A FI 763473 A FI763473 A FI 763473A
Authority
FI
Finland
Application number
FI763473A
Other languages
Finnish (fi)
Other versions
FI57599C (fi
FI57599B (fi
Inventor
Wolf Von Daehne
Poul Rodbroe Rasmussen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB49714/75A external-priority patent/GB1565954A/en
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI763473A publication Critical patent/FI763473A/fi
Application granted granted Critical
Publication of FI57599B publication Critical patent/FI57599B/fi
Publication of FI57599C publication Critical patent/FI57599C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
FI763473A 1975-12-03 1976-12-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fusida-13(17)-en-21-karboxylsyraderivat FI57599C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4971475 1975-12-03
GB49714/75A GB1565954A (en) 1975-12-03 1975-12-03 Fusidic acid derivatives
GB1601576 1976-04-20
GB1601576 1976-04-20

Publications (3)

Publication Number Publication Date
FI763473A true FI763473A (xx) 1977-06-04
FI57599B FI57599B (fi) 1980-05-30
FI57599C FI57599C (fi) 1980-09-10

Family

ID=26251702

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763473A FI57599C (fi) 1975-12-03 1976-12-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fusida-13(17)-en-21-karboxylsyraderivat

Country Status (20)

Country Link
US (2) US4100276A (xx)
JP (1) JPS5271459A (xx)
AT (1) AT343810B (xx)
AU (1) AU501066B2 (xx)
CA (1) CA1079267A (xx)
DE (1) DE2654508A1 (xx)
DK (1) DK142852B (xx)
ES (1) ES453853A1 (xx)
FI (1) FI57599C (xx)
FR (1) FR2333807A1 (xx)
GR (1) GR62007B (xx)
IE (1) IE44263B1 (xx)
IT (1) IT1074295B (xx)
LU (1) LU76313A1 (xx)
NL (1) NL7613445A (xx)
NZ (1) NZ182661A (xx)
PT (1) PT65925B (xx)
SE (1) SE410859B (xx)
SU (1) SU679146A3 (xx)
YU (1) YU291176A (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4162259A (en) * 1975-12-03 1979-07-24 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske fabrik Produktionsaktienselskab) Fusidic acid derivatives
IE44263B1 (en) * 1975-12-03 1981-09-23 Leo Pharm Prod Ltd New fusidic acid derivatives
US4548922A (en) * 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US4959358A (en) * 1983-06-06 1990-09-25 Beth Israel Hospital Assn. Drug administration
US6255299B1 (en) * 1985-01-07 2001-07-03 Leo Pharmaceutical Products Ltd. Opthalmic gel composition and method of treating eye infections
GB8500310D0 (en) * 1985-01-07 1985-02-13 Leo Pharm Prod Ltd Pharmaceutical preparation
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
CA2062792C (en) * 1989-07-07 2006-03-21 Fernard Labrie Treatment of androgen-related diseases
EP0485392B1 (en) * 1989-07-07 1998-09-09 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)
US5454801A (en) * 1992-10-09 1995-10-03 Mcneil-Ppc, Inc. Printed polymer coatings and method for making same
US5658560A (en) * 1994-01-18 1997-08-19 Serikov; Vladimir B. Method of treating endotoxemia by administering tyloxapol
MY140194A (en) * 2003-07-16 2009-11-30 Leo Pharma As Novel fusidic acid derivatives
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1447489A (en) * 1972-10-06 1976-08-25 Leo Pharm Prod Ltd Fusidic acid conjugates
GB1490852A (en) * 1974-09-12 1977-11-02 Leo Pharm Prod Ltd Fusidic acid derivatives
IE44263B1 (en) * 1975-12-03 1981-09-23 Leo Pharm Prod Ltd New fusidic acid derivatives

Also Published As

Publication number Publication date
GR62007B (en) 1979-02-15
AU1986876A (en) 1978-06-01
AU501066B2 (en) 1979-06-07
IE44263B1 (en) 1981-09-23
NL7613445A (nl) 1977-06-07
PT65925A (en) 1977-01-01
PT65925B (en) 1978-06-13
IE44263L (en) 1977-06-03
DE2654508A1 (de) 1977-06-08
DK142852C (xx) 1981-09-21
JPS5271459A (en) 1977-06-14
FR2333807A1 (fr) 1977-07-01
LU76313A1 (xx) 1977-06-21
US4315004A (en) 1982-02-09
NZ182661A (en) 1979-07-11
SE7613565L (sv) 1977-06-04
AT343810B (de) 1978-06-26
FI57599C (fi) 1980-09-10
SE410859B (sv) 1979-11-12
ES453853A1 (es) 1978-01-16
FI57599B (fi) 1980-05-30
DK142852B (da) 1981-02-09
DK539476A (xx) 1977-06-04
SU679146A3 (ru) 1979-08-05
FR2333807B1 (xx) 1980-11-07
US4100276A (en) 1978-07-11
ATA887576A (de) 1977-10-15
CA1079267A (en) 1980-06-10
IT1074295B (it) 1985-04-20
YU291176A (en) 1982-05-31

Similar Documents

Publication Publication Date Title
JPS5742023Y2 (xx)
JPS523119U (xx)
JPS558658B2 (xx)
JPS5248687U (xx)
JPS5234528U (xx)
JPS55922Y2 (xx)
JPS5278052U (xx)
JPS5219350U (xx)
JPS5210884U (xx)
JPS5194098U (xx)
JPS5193277U (xx)
JPS5190681U (xx)
CH600215A5 (xx)
CH599297A5 (xx)
CH604443A5 (xx)
CH604382A5 (xx)
CH603697A5 (xx)
CH603193A5 (xx)
AU483860A (xx)
CH602971A5 (xx)
CH602458A5 (xx)
CH602382A5 (xx)
CH601947A5 (xx)
CH596282A5 (xx)
CH599544A5 (xx)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: LEO PHARMACEUTICAL PRODUCTS LTD A/S (LOEVENS KEMIS